Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure | Charles Explorer

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

Publication at Faculty of Physical Education and Sport |

2005

Abstract

eplerenone, acute myocardial infarction

Person